What does CUSIP 035255108 represent in this 13F holders report?

CUSIP 035255108 is the security identifier for ANIK - Anika Therapeutics Inc - Common Stock used to aggregate holder disclosures.

How many institutions held ANIK - Anika Therapeutics Inc - Common Stock in Q1 2021?

144 institutional investors reported ANIK - Anika Therapeutics Inc - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

Anika Therapeutics Inc - Common Stock (ANIK)

CUSIP: 035255108

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 13,404,566
Total 13F shares: 13,310,684
Share change: -245,815
Total reported value: $543,030,178
Put/Call ratio: 3.8%
Price per share: $40.79
Number of holders: 144
Value change: -$15,429,177
Number of buys: 61
Number of sells: 79

Quarterly Holders Quick Answers

What is CUSIP 035255108?
CUSIP 035255108 identifies ANIK - Anika Therapeutics Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 035255108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ANIK - Anika Therapeutics Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	17%	2,250,290	$101,849,000	—	31 Dec 2020	13F
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC	13F	Company	12%	1,546,260	$69,984,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	7.5%	1,004,108	$45,445,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	7%	934,282	$42,286,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	6.6%	884,116	$40,015,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	6.1%	820,746	$37,147,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	6%	809,117	$36,621,000	—	31 Dec 2020	13F
Avidity Partners Management LP	13F	Company	5.5%	731,000	$33,085,000	—	31 Dec 2020	13F
Boston Trust Walden Corp	13F	Company	2.8%	378,167	$17,116,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	1.7%	229,759	$10,399,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.6%	213,001	$9,640,000	—	31 Dec 2020	13F
Russell Investments Group, Ltd.	13F	Company	1.5%	206,461	$9,341,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	1.5%	195,870	$8,865,000	—	31 Dec 2020	13F
NATIXIS ADVISORS, LLC	13F	Company	1.3%	169,063	$7,652,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	1.2%	159,197	$7,205,000	—	31 Dec 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	1.2%	156,895	$7,101,000	—	31 Dec 2020	13F
Baird Financial Group, Inc.	13F	Company	1%	136,300	$6,169,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.85%	113,551	$5,140,000	—	31 Dec 2020	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.82%	109,788	$4,969,000	—	31 Dec 2020	13F
Parian Global Management LP	13F	Company	0.77%	102,705	$4,648,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.73%	97,284	$4,403,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.7%	93,507	$4,233,000	—	31 Dec 2020	13F
CAPITAL MANAGEMENT CORP /VA	13F	Company	0.69%	93,035	$4,211,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.62%	82,783	$3,747,000	—	31 Dec 2020	13F
Foundry Partners, LLC	13F	Company	0.58%	78,380	$3,547,000	—	31 Dec 2020	13F
Ranger Investment Management, L.P.	13F	Company	0.57%	75,995	$3,440,000	—	31 Dec 2020	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.51%	68,688	$3,109,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.51%	67,987	$3,077,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.49%	65,612	$2,969,000	—	31 Dec 2020	13F
Sio Capital Management, LLC	13F	Company	0.49%	65,382	$2,959,000	—	31 Dec 2020	13F
Zweig-DiMenna Associates LLC	13F	Company	0.46%	61,090	$2,765,000	—	31 Dec 2020	13F
STIFEL FINANCIAL CORP	13F	Company	0.4%	53,316	$2,413,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.39%	52,234	$2,364,000	—	31 Dec 2020	13F
ROYAL BANK OF CANADA	13F	Company	0.38%	51,508	$2,331,000	—	31 Dec 2020	13F
Archon Capital Management LLC	13F	Company	0.36%	48,925	$2,214,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.36%	48,545	$2,197,000	—	31 Dec 2020	13F
Euclidean Technologies Management, LLC	13F	Company	0.33%	44,875	$2,031,000	—	31 Dec 2020	13F
Assenagon Asset Management S.A.	13F	Company	0.31%	41,288	$1,869,000	—	31 Dec 2020	13F
Legal & General Group Plc	13F	Company	0.3%	40,140	$1,817,000	—	31 Dec 2020	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.28%	38,100	$1,724,000	—	31 Dec 2020	13F
J.P. Morgan Private Wealth Advisors LLC	13F	Company	0.28%	37,920	$1,716,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.28%	37,000	$1,675,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.24%	31,900	$1,444,000	—	31 Dec 2020	13F
PUBLIC SECTOR PENSION INVESTMENT BOARD	13F	Company	0.23%	31,446	$1,423,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.23%	31,339	$1,418,000	—	31 Dec 2020	13F
ENVESTNET ASSET MANAGEMENT INC	13F	Company	0.22%	30,125	$1,363,000	—	31 Dec 2020	13F
PRIO WEALTH LIMITED PARTNERSHIP	13F	Company	0.22%	30,060	$1,361,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.2%	26,492	$1,200,000	—	31 Dec 2020	13F
Fisher Asset Management, LLC	13F	Company	0.19%	26,040	$1,179,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.18%	24,290	$1,099,000	—	31 Dec 2020	13F

Institutional Holders of Anika Therapeutics Inc - Common Stock (ANIK) as of Q1 2021

As of 31 Mar 2021, Anika Therapeutics Inc - Common Stock (ANIK) was held by 144 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,310,684 shares. The largest 10 holders included BlackRock Inc., KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, STATE STREET CORP, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, Boston Trust Walden Corp, and FORT WASHINGTON INVESTMENT ADVISORS INC /OH/. This page lists 144 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

156

Q1 2021 holders

144

Holder diff

-12

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.